Antibiotic-Resistant Gonorrhea on the Rise in the United States

Share this content:
Antibiotic-Resistant Gonorrhea on the Rise in the United States
Antibiotic-Resistant Gonorrhea on the Rise in the United States

FRIDAY, July 15, 2016 (HealthDay News) -- Antibiotic-resistant cases of gonorrhea have more than quadrupled in the United States, according to research published in the July 15 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

This new data should serve as a warning that "the future of current treatment options may be in jeopardy," the CDC said in a news release issued Thursday.

For now, the multidrug therapy that the CDC recommends for gonorrhea still works, the agency said, and there's not yet been a U.S. case where treatment completely failed. However, agency researchers report that the number of U.S. cases of gonorrhea where strains showed decreased susceptibility to azithromycin jumped from 0.6 percent in 2013 to 2.5 percent a year later. This suggests that azithromycin "will be next in the long line of antibiotics to which gonorrhea bacteria have become resistant -- a list that includes penicillin, tetracycline, and fluoroquinolones," the CDC said.

"It is unclear whether these increases mark the beginning of trends, but emergence of cephalosporin and azithromycin resistance would complicate gonorrhea treatment substantially," the authors write.

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Florida Teen First Human Case of Another Mosquito-Borne Virus

Florida Teen First Human Case of Another Mosquito-Borne ...

First documented case of Keystone infection in a human

70 Sickened So Far in Salmonella-Tainted Melon Outbreak

70 Sickened So Far in Salmonella-Tainted Melon Outbreak

Illnesses reported in Illinois, Indiana, Kentucky, Michigan, Missouri, Ohio, and Tennessee

AAFP Still Recommends CRC Screening From Age 50 to 75

AAFP Still Recommends CRC Screening From Age 50 ...

Despite ACS change to start screening from age 45 years, AAFP agrees with USPSTF recommendation

is free, fast, and customized just for you!




Already a member?

Sign In Now »